|
decitabine |
|---|---|
| Trade Name | |
| Orphan Indication | Chronic myeloid leukemia |
| USA Market Approval | USA |
| USA Designation Date | 1999-03-08 00:00:00 |
| Sponsor | Otsuka Pharmaceutical Development &;Commercialization, Inc., 508 Carnegie Center Drive;Princeton, New Jersey, 08540 |
Related Access Program
Pusan National University Hospital – Chronic Myeloid Leukemia
University of California, San Francisco – Chronic Myeloid Leukemia
Emory University – Chronic Myeloid Leukemia
Pusan National University Hospital – Chronic myeloid leukemia
University of California, San Francisco – Chronic myeloid leukemia
Pfizer – Chronic myeloid leukemia
Emory University – Chronic myeloid leukemia
